J. De Vos et al., Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays, BLOOD, 98(3), 2001, pp. 771-780
In multiple myeloma (MM), the growth of primary plasma cells depends not on
ly on interieukin-6 (IL-6), but also on additional unidentified signals del
ivered by the bone marrow environment. Using Atlas complementary DNA (cDNA)
arrays comprising 268 genes coding for intercellular signaling molecules,
this study Identified genes that are overexpressed in myeloma cells compare
d to autologous B-lymphoblastoid cell lines. These genes encode the oncogen
ic Tyro3 tyrosine kinase receptor, the heparin-binding epidermal growth fac
tor-like growth factor (HB-EGF) that Is an epithelial autocrine tumor growt
h factor, the thrombin receptor (TR) that is linked to HB-EGF and syndecan-
1 processing and to cell invasion, chemokine receptors CCR1 and CCR2, the W
nt pathway actor Frizzled-related protein (FRZB), and the Notch receptor li
gand Jagged 2. These data, obtained with the Atlas cDNA array, were confirm
ed by reverse transcriptase-polymerase chain reaction or protein analysis o
r both. Furthermore, Tyro3, HB-EGF, TR, and FRZB gene expression was docume
nted in purified primary malignant plasma cells from patients with plasma c
ell leukemia or MM. HB-EGF and FRZB were poorly expressed in purified polyc
lonal plasma cells. Finally, HB-EGF was proved to be an essential autocrine
growth factor for the XG-1 myeloma cells. This study shows the potency and
the biologic relevance of cDNA arrays used to analyze simultaneously a lar
ge panel of intercellular signaling genes and, by identifying several genes
overexpressed in malignant plasma cells, opens new fields of investigation
in MM biology. (C) 2001 by The American Society of Hematology.